Induction chemotherapy with capecitabine and oxaliplatin followed by chemoradiotherapy before surgery in patients with locally advanced rectal cancer (A phase II study)
ConclusionInduction chemotherapy could be a promising option for better response rates either clinical or pathological for high risk LARC patients with acceptable toxicity profile.
Source: QJM - Category: Internal Medicine Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Eloxatin | Internal Medicine | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Rectal Cancers | Study | Toxicology | Xeloda